These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6687802)

  • 1. Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor II.
    Griffith MJ; Marbet GA
    Biochem Biophys Res Commun; 1983 Apr; 112(2):663-70. PubMed ID: 6687802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin.
    Liaw PC; Becker DL; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2001 Jun; 276(24):20959-65. PubMed ID: 11294849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of dermatan sulfate with high heparin cofactor II-mediated thrombin-inhibitory activity from porcine spleen.
    Munakata H; Hsu CC; Kodama C; Aikawa J; Sakurada M; Ototani N; Isemura M; Yosizawa Z; Hayashi N
    Biochim Biophys Acta; 1987 Sep; 925(3):325-31. PubMed ID: 3620505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of heparin cofactor II by heparin and dermatan sulfate.
    Tollefsen DM
    Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.
    Tollefsen DM; Peacock ME; Monafo WJ
    J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II.
    Yamagishi R; Koide T; Sakuragawa N
    FEBS Lett; 1987 Dec; 225(1-2):109-12. PubMed ID: 3691797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity chromatography of sulphated polysaccharides separately fractionated on antithrombin III and heparin cofactor II immobilized on concanavalin A--sepharose.
    Sinniger V; Tapon-Bretaudière J; Millien C; Muller D; Jozefonvicz J; Fischer AM
    J Chromatogr; 1993 Jun; 615(2):215-23. PubMed ID: 8335699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of heparin cofactor II by dermatan sulfate.
    Tollefsen DM; Pestka CA; Monafo WJ
    J Biol Chem; 1983 Jun; 258(11):6713-6. PubMed ID: 6687888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
    Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
    J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
    Ofosu FA; Fernandez F; Gauthier D; Buchanan MR
    Semin Thromb Hemost; 1985 Apr; 11(2):133-7. PubMed ID: 3898370
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
    Ofosu FA; Modi GJ; Smith LM; Cerskus AL; Hirsh J; Blajchman MA
    Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate.
    Blinder MA; Andersson TR; Abildgaard U; Tollefsen DM
    J Biol Chem; 1989 Mar; 264(9):5128-33. PubMed ID: 2647747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.
    Mascellani G; Liverani L; Parma B; Bergonzini G; Bianchini P
    Thromb Res; 1996 Oct; 84(1):21-32. PubMed ID: 8885144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histidine-rich glycoprotein inhibits the antithrombin activity of heparin cofactor II in the presence of heparin or dermatan sulfate.
    Niwa M; Yamagishi R; Kondo S; Sakuragawa N; Koide T
    Thromb Res; 1985 Jan; 37(1):237-40. PubMed ID: 3838602
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
    Maimone MM; Tollefsen DM
    J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen inhibits the heparin cofactor II-mediated antithrombin activity of dermatan sulfate.
    Zammit A; Dawes J
    Blood; 1995 Feb; 85(3):720-6. PubMed ID: 7833476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin cofactor II activation by dermatan sulfate.
    Tollefsen DM; Maimone MM; McGuire EA; Peacock ME
    Ann N Y Acad Sci; 1989; 556():116-22. PubMed ID: 2660682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.